SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-018825
Filing Date
2019-01-28
Accepted
2019-01-28 16:02:37
Documents
4
Effectiveness Date
2019-01-28

Document Format Files

Seq Description Document Type Size
1 S-8 d694269ds8.htm S-8 76409
2 EX-5.1 d694269dex51.htm EX-5.1 4764
3 EX-23.1 d694269dex231.htm EX-23.1 1464
4 GRAPHIC g694269g74c61.jpg GRAPHIC 3440
  Complete submission text file 0001193125-19-018825.txt   88539
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-229392 | Film No.: 19545475
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1